Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer[1].
Molecular Weight:
390.66
Purity:
99.75
CAS Number:
[1983984-01-5]
Formula:
C13H14Cl3N7O
Target:
CDK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted